A vaccine covers five meningococcal groups

Yirenkyi described pilot services that began in 2017, distinguishing their start from the interview date.

The interview discussed Ghana’s centre for plant-based medicine and links with universities.

Yirenkyi described professional training, registration and quality oversight.

A news release described a March vaccination campaign using Men5CV against five meningococcal groups.

The article explains why vaccination was undertaken in affected Nigerian states.

The entry is dated to WHO’s 12 April report; the initial rollout took place in March.

WHO prequalified the TAK-003 dengue vaccine on 10 May, later reporting the decision.

The prequalification supports procurement for countries with appropriate dengue vaccine policies.

The vaccine is recommended for children in particular high-transmission settings, not for every population.

The decision was one step in dengue prevention alongside mosquito control and clinical care.